4//SEC Filing
CENTPHARM LLC 4
Accession 0001181431-04-008033
CIK 0001118361other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 11:25 AM ET
Size
11.5 KB
Accession
0001181431-04-008033
Insider Transaction Report
Form 4
RENOVIS INCRNVS
CENTPHARM LLC
Director10% Owner
Transactions
- Conversion
Common Stock
2004-02-10+2,577,777→ 2,577,777 total(indirect: Escrow Agent) - Conversion
Series D Preferred Stock
2004-02-10−11,600,000→ 0 total(indirect: Escrow Agent)→ Common Stock (2,577,777 underlying) - Conversion
Series D Preferred Stock
2004-02-10−1,100,000→ 0 total→ Common Stock (244,444 underlying) - Conversion
Common Stock
2004-02-10+244,444→ 244,444 total
Footnotes (5)
- [F1]Reflects the 1-for-4.5 reverse stock split effected prior to the effectiveness of the Issuer's initial public offering.
- [F2]The securities are held by Embassy & Co. as escrow agent. CentPharm, LLC controls the voting of the shares held by Embassy & Co. as escrow agent.
- [F3]Each one share of Series D Preferred Stock automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- [F4]Does not reflect the 1-for-4.5 reverse stock split effected prior to the effectiveness of the Issuer's initial public offering.
- [F5]Expiration date is irrelevant.
Documents
Issuer
RENOVIS INC
CIK 0001118361
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001278727
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 11:25 AM ET
- Size
- 11.5 KB